Dr. Baysal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-3427
Education & Training
Yale-New Haven Medical CenterFellowship, Hematopathology, 2010 - 2011- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2007 - 2010
OtherClass of 1988
Certifications & Licensure
CA State Medical License 2020 - 2026
FL State Medical License 2022 - 2026
NY State Medical License 2010 - 2025
TX State Medical License 2022 - 2025- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 27 citationsAnalysis of CHEK2 gene for ovarian cancer susceptibility.Bora E. Baysal, Julie A. DeLoia, Joan E. Willett-Brozick, Marc T. Goodman, Mark F. Brady
Gynecologic Oncology. 2004-10-01 - 57 citationsRelationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cis...Thomas C. Krivak, Kathleen M. Darcy, Chunqiao Tian, Deborah K. Armstrong, Bora E. Baysal
Journal of Clinical Oncology. 2008-07-20 - 50 citationsHigh-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.Cathy B. Wilcox, Bora E. Baysal, Holly H. Gallion, Mary Strange, Julie A. DeLoia
Cancer Genetics and Cytogenetics. 2005-06-01
Press Mentions
Purposeful 'Editing' of RNA in Immune Cells May Be Linked to Viral Infections and CancerJune 27th, 2020
Grant Support
- Epigenetic Regulation Of Mitochondiral Complex IINational Cancer Institute2005–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
